MHC I-dependent Antigen Presentation is Inhibited by Poliovirus Protein 3A

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2000 Nov 30

PMID 11095746

Citations 87

Authors

S B Deitz

D A Dodd

S Cooper

P Parham

K Kirkegaard

Affiliations

Soon will be listed here.

Abstract

The effects of poliovirus 3A protein expression and poliovirus infection on the presentation of hepatitis C virus antigens in cultured chimpanzee cells were examined. Expression of poliovirus 3A protein inhibits protein secretion when expressed in isolation and was sufficient to protect chimpanzee cells from lysis by hepatitis C virus-specific cytotoxic T cells in standard (51)Cr-release assays. Poliovirus infection also inhibited antigen presentation, as determined by decreased cytotoxic T cell activation. A mutation in 3A that abrogates the inhibition of protein secretion also abolished the effects of poliovirus on antigen presentation. These results demonstrate that the inhibition of secretion observed in poliovirus-infected cells substantially reduces the presentation of new antigens on the cell surface. These observations may reflect a general mechanism by which nonenveloped viruses such as poliovirus and other viruses that do not require a functional protein secretory apparatus can evade detection by the cellular immune response.

Citing Articles

Enterovirus 3A protein disrupts endoplasmic reticulum homeostasis through interaction with GBF1.

Hirano J, Hayashi T, Kitamura K, Nishimura Y, Shimizu H, Okamoto T J Virol. 2024; 98(7):e0081324.

PMID: 38904364 PMC: 11265424. DOI: 10.1128/jvi.00813-24.

Seneca Valley virus replicons are packaged in and have the capacity to overcome the limitations of viral transgene expression.

Bryant J, Lee J, de Almeida A, Jacques J, Chang C, Fassler W Mol Ther Oncolytics. 2023; 28:321-333.

PMID: 36938543 PMC: 10018389. DOI: 10.1016/j.omto.2023.02.005.

Inhibitory Effects of Infection on MHC-I Expression in Bone Marrow Derived Dendritic Cells.

Rezvan H, Ali S, Hamoon Navard S Iran J Parasitol. 2023; 17(4):562-572.

PMID: 36660416 PMC: 9825691. DOI: 10.18502/ijpa.v17i4.11284.

SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression.

Arshad N, Laurent-Rolle M, Ahmed W, Hsu J, Mitchell S, Pawlak J Proc Natl Acad Sci U S A. 2022; 120(1):e2208525120.

PMID: 36574644 PMC: 9910621. DOI: 10.1073/pnas.2208525120.

Functions of Viroporins in the Viral Life Cycle and Their Regulation of Host Cell Responses.

Xia X, Cheng A, Wang M, Ou X, Sun D, Mao S Front Immunol. 2022; 13:890549.

PMID: 35720341 PMC: 9202500. DOI: 10.3389/fimmu.2022.890549.

References

Doedens J, Kirkegaard K . Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J. 1995; 14(5):894-907. PMC: 398162. DOI: 10.1002/j.1460-2075.1995.tb07071.x. View

Erickson A, Houghton M, Choo Q, Weiner A, Ralston R, Muchmore E . Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol. 1993; 151(8):4189-99. View

Koike S, Taya C, Kurata T, Abe S, Ise I, Yonekawa H . Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci U S A. 1991; 88(3):951-5. PMC: 50932. DOI: 10.1073/pnas.88.3.951. View

Darnell R . Immunologic complexity in neurons. Neuron. 1998; 21(5):947-50. DOI: 10.1016/s0896-6273(00)80613-3. View

Ren R, Costantini F, Gorgacz E, Lee J, Racaniello V . Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell. 1990; 63(2):353-62. DOI: 10.1016/0092-8674(90)90168-e. View

Eberl G, Widmann C, Corradin G . The functional half-life of H-2Kd-restricted T cell epitopes on living cells. Eur J Immunol. 1996; 26(9):1993-9. DOI: 10.1002/eji.1830260904. View

Mandl S, Sigal L, Rock K, Andino R . Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen. Proc Natl Acad Sci U S A. 1998; 95(14):8216-21. PMC: 20956. DOI: 10.1073/pnas.95.14.8216. View

Aldabe R, Carrasco L . Induction of membrane proliferation by poliovirus proteins 2C and 2BC. Biochem Biophys Res Commun. 1995; 206(1):64-76. DOI: 10.1006/bbrc.1995.1010. View

Brodsky F, Lem L, Solache A, Bennett E . Human pathogen subversion of antigen presentation. Immunol Rev. 1999; 168:199-215. DOI: 10.1111/j.1600-065x.1999.tb01294.x. View

10.

Brodsky F, Bodmer W, Parham P . Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur J Immunol. 1979; 9(7):536-45. DOI: 10.1002/eji.1830090709. View

11.

Davis J, Cresswell P . Lack of detectable endocytosis of B lymphocyte MHC class II antigens using an antibody-independent technique. J Immunol. 1990; 144(3):990-7. View

12.

Kane K, Vitiello A, Sherman L, Mescher M . Cytolytic T-lymphocyte response to isolated class I H-2 proteins and influenza peptides. Nature. 1989; 340(6229):157-9. DOI: 10.1038/340157a0. View

13.

Malik P, Baba E, Strominger J . Biotinylation of class I MHC molecules abrogates recognition by W6/32 antibody. Tissue Antigens. 1999; 53(6):576-9. DOI: 10.1034/j.1399-0039.1999.530609.x. View

14.

Teterina N, Gorbalenya A, Egger D, Bienz K, EHRENFELD E . Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J Virol. 1997; 71(12):8962-72. PMC: 230196. DOI: 10.1128/JVI.71.12.8962-8972.1997. View

15.

Kutubuddin M, Simons J, Chow M . Poliovirus-specific major histocompatibility complex class I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regions. J Virol. 1992; 66(10):5967-74. PMC: 241474. DOI: 10.1128/JVI.66.10.5967-5974.1992. View

16.

Schlegel A, Giddings Jr T, Ladinsky M, Kirkegaard K . Cellular origin and ultrastructure of membranes induced during poliovirus infection. J Virol. 1996; 70(10):6576-88. PMC: 190698. DOI: 10.1128/JVI.70.10.6576-6588.1996. View

17.

Mahon B, Katrak K, Nomoto A, Macadam A, Minor P, Mills K . Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J Exp Med. 1995; 181(4):1285-92. PMC: 2191967. DOI: 10.1084/jem.181.4.1285. View

18.

Ploegh H . Viral strategies of immune evasion. Science. 1998; 280(5361):248-53. DOI: 10.1126/science.280.5361.248. View

19.

Doedens J, Giddings Jr T, Kirkegaard K . Inhibition of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: genetic and ultrastructural analysis. J Virol. 1997; 71(12):9054-64. PMC: 230206. DOI: 10.1128/JVI.71.12.9054-9064.1997. View

20.

Cho M, Teterina N, Egger D, Bienz K, EHRENFELD E . Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology. 1994; 202(1):129-45. DOI: 10.1006/viro.1994.1329. View